Skip to main content
Enovis Corporation (ENOV)
NYSE: ENOV · Real-Time Price · USD
22.78
-0.62 (-2.65%)
Apr 29, 2026, 10:55 AM EDT - Market open

Enovis Revenue

In the year 2025, Enovis had annual revenue of $2.25B with 6.66% growth. Enovis had revenue of $575.76M in the quarter ending December 31, 2025, with 2.64% growth.

Revenue (ttm)
$2.25B
Revenue Growth
+6.66%
P/S Ratio
0.60
Revenue / Employee
$288,138
Employees
7,802
Market Cap
1.31B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20252.25B140.43M6.66%
Dec 31, 20242.11B400.43M23.46%
Dec 31, 20231.71B144.10M9.22%
Dec 31, 20221.56B136.91M9.60%
Dec 31, 20211.43B305.49M27.26%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AdaptHealth 3.24B
CONMED 1.37B
Tandem Diabetes Care 1.01B
Inspire Medical Systems 911.98M
Alphatec Holdings 764.16M
Avanos Medical 701.20M
NovoCure 655.35M
UFP Technologies 602.80M
Revenue Rankings

ENOV News

More News